Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID

Virology

Volumn 251, Issue 2, 1998, Pages 383-392

  Yuan, Hang ^a   Yoza, Barbara K ^a   Lyles, Douglas S ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; RNA POLYMERASE II; TATA BINDING PROTEIN;

ARTICLE; CELL FRACTIONATION; ENZYME ASSAY; GENE REPRESSION; GENETIC TRANSCRIPTION; HELA CELL; IMMUNOBLOTTING; MESSENGER RNA SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

EID: 0032567085     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9413     Document Type: Article

References (38)

1. Ahmed M., Lyles D. S. Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression. Virology. 237:1997;378-388.
2. Ahmed M., Lyles D. S. Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerase I, II, and III. J. Virol. 72:1998;8413-8419.
3. Baxt B., Bablanian R. Mechanisms of vesicular stomatitis virus-induced cytopathic effects. II. Inhibition of macromolecular synthesis induced by infectious and defective-interfering particles. Virology. 72:1976;383-392.
4. Black B. L., Lyles D. S. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J. Virol. 66:1992;4058-4064.
5. Black B. L., Rhodes R. B., McKenzie M., Lyles D. S. The role of vesicular stomatitis virus matrix protein in inhibition of host-directed gene expression is genetically separable from its function in virus assembly. J. Virol. 67:1993;4814-4821.
6. Burley S. K., Roeder R. G. Biochemistry and structural biology of transcription factor IID (TFIID). Annu. Rev.Biochem. 65:1996;769-799.
7. Clark M. E., Lieberman P. M., Berk A. J., Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol. Cell. Biol. 13:1993;1232-1237.
8. Coulon P., Deutsch V., Lafay F., Martinet-Edelist C., Wyers F., Herman R. C., Flamand A. Genetic evidence for multiple functions of the matrix protein of vesicular stomatitis virus. J. Gen. Virol. 71:1990;991-996.
9. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
10. Dunigan D. D., Baird S., Lucas-Lenard J. Lack of correlation between the accumulation of plus-strand leader RNA and the inhibition of protein and RNA synthesis in vesicular stomatitis virus infected mouse L cells. Virology. 150:1986;231-246.
11. Dynlacht B. D., Hoey T., Tjian R. Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation. Cell. 66:1991;563-576.
12. Ferran M. C., Lucas-Lenard J. M. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 71:1997;371-377.
13. Fresco L. D., Kurilla M. G., Keene J. D. Rapid inhibition of processing and assembly of small nuclear ribonucleoproteins after infection with vesicular stomatitis virus. Mol. Cell. Biol. 7:1987;1148-1155.
14. Grinnell B. W., Wagner R. R. Nucleotide sequence and secondary structure of VSV leader RNA and homologous DNA involved in inhibition of DNA-dependent transcription. Cell. 36:1984;533-543.
15. Grinnell B. W., Wagner R. R. Inhibition of DNA-dependent transcription by the leader RNA of vesicular stomatitis virus: role of specific nucleotide sequences and cell protein binding. Mol. Cell. Biol. 5:1985;2502-2513.
16. Hardwick J. M., Griffin D. E. Viral effects on cellular functions. Viral Pathogenesis. 1997;Lippincott-Raven, New York. p. 55-83.
17. Her L. S., Lund E., Dahlberg J. E. Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science. 276:1997;1845-1848.
18. Kashanchi F., Piras G., Radonovich M. F., Duvall J. F., Fattaey A., Chiang C. M., Roeder R. G., Brady J. N. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature. 367:1994;295-299.
19. Kliewer S., Dasgupta A. An RNA polymerase II transcription factor inactivated in poliovirus-infected cells copurifies with transcription factor TFIID. Mol. Cell. Biol. 8:1988;3175-3182.
20. Lenard J. Negative-strand virus M and retrovirus MA protein: All in a family. Virology. 216:1996;289-292.
21. Lyles D. S., McKenzie M. O. Activity of vesicular stomatitis virus M protein mutants in cell rounding is correlated with the ability to inhibit host gene expression and is not correlated with virus assembly function. Virology. 229:1997;77-89.
22. Lyles D. S., McKenzie M. O., Ahmed M., Woolwine S. C. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression. Virology. 225:1996;172-180.
23. Maldonado E., Drapkin R., Reinberg D. Purification of human RNA polymerase II and general transcription factors. Methods Enzymol. 274:1996;72-100.
24. McGowan J. J., Emerson S. U., Wagner R. R. The plus-strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus and SV40 genes in a soluble whole-cell extract. Cell. 28:1982;325-333.
25. McGowan J. J., Wagner R. R. Inhibition of cellular DNA synthesis by vesicular stomatitis virus. J. Virol. 38:1981;356-367.
26. Paik S. Y., Banerjea A. C., Harmison G. G., Chen C. J., Schubert M. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. J. Virol. 69:1995;3529-3537.
27. Poellinger L., Yoza B. K., Roeder R. G. Functional cooperativity between protein molecules bound at two distinct sequence elements of the immunoglobulin heavy chain promoter. Nature. 337:1989;573-576.
28. Poirot M. K., Schnitzlein W. M., Reichmann M. E. The requirement of protein synthesis for VSV inhibition of host cell RNA synthesis. Virology. 140:1985;91-101.
29. Rank N. M., Lambert P. F. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB. J. Virol. 69:1995;6323-6334.
30. Reinberg D., Roeder R. G. Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE. J. Biol. Chem. 26:1987;3310-3321.
31. Roeder R. G. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:1996;327-335.
32. Sawadogo M., Roeder R. G. Interaction of a gene-specific transcription factor with adenovirus major late promoter upstream of the TATA box region. Cell. 43:1985;165-175.
33. Tyree C. M., George C. P., Lira-DeVito L. M., Wampler S. L., Dahmus M. E., Zawel L., Kadonaga J. T. Identification of a minimal set of proteins that is sufficient for accurate initiation of transcription by RNA polymerase II. Genes Dev. 7:1993;1254-1265.
34. Wagner R. R., Huang A. S. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology. 28:1966;1-10.
35. Wang H. D., Yuh C. H., Dang C. V., Johnson D. L. The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. Mol. Cell. Biol. 15:1995;6720-6728.
36. Weck P. K., Wagner R. R. Transcription of vesicular stomatitis virus is required to shut off cellular RNA synthesis. J. Virol. 30:1979a;410-413.
37. Weck P. K., Wagner R. R. Vesicular stomatitis virus infection reduces the number of active DNA-dependent RNA polymerases in myeloma cells. J. Biol. Chem. 254:1979b;5430-5434.
38. Wertz G. W., Youngner J. S. Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus. J. Virol. 6:1970;476-484.